Supporting global industrial scale-up at a pandemic speed with Type 1 pharma glass containers and timely solutions
In a compressed timeframe, producing large quantities of pharmaceutical glass containers to deliver the coronavirus vaccine around the world is a critical factor for a successful global response. Type 1 glass is a proven and widely available solution for pharma glass containers that preserves the stability of vaccines. Players in the pharmaceutical supply chain are committed to supporting pharmaceutical companies and governments in the fight against the pandemic.
From the beginning of the coronavirus, Stevanato Group, as a leading producer of glass primary packaging and provider of integrated capabilities for drug delivery systems based in Italy, increased its worldwide production capacity of glass containers to secure SARS-CoV-2 treatments and vaccines while protecting its staff.
The company has implemented health and safety measures according to national and regional regulations and maximized the use of remote working and communication systems in all its global operations.
Ensuring the timely supply of high-quality glass primary packaging, technologies and services at a pandemic speed
Conscious of its essential role in addressing the public health emergency, Stevanato Group deployed all its available assets to ensure the timely supply of its integrated offering to healthcare companies. They range from high-quality glass primary packaging, also sterilized, plastic consumables for diagnostic kits for virus detection, advanced analytical testing, visual inspection systems of filled containers, and packaging equipment.
For more information on the integrated offering, click here
Stevanato Group has also potentiated its digital tools to assist pharmaceutical companies in these times of reduced travel and social distancing, implementing remote FAT and SATs and remote virtual audits.
A dedicated coronavirus taskforce has been active since the beginning of the pandemic to address any commercial inquiry and identify the best suited and timely solution.
Moreover, confirming its strong commitment to the territory in which it was born, Stevanato Group decided to donate an initial amount of EUR 500,000 to support a multitude of healthcare structures operating in the Veneto region.
A significant contribution to the fight of the pandemic: the agreement with CEPI
Last June, Stevanato Group signed an agreement with the Coalition for Epidemic Preparedness Innovations (CEPI), the global partnership at the forefront of funding and coordinating the development of COVID-19 vaccine candidates. The agreement foresees the provision of 100 million pharma glass vials manufactured at its facilities in Italy and Mexico for up to 2 billion doses of COVID-19 vaccines under development and a "fast track" access to Stevanato Group glass forming lines provided by its company Spami.
CEPI is currently investing up to US $829 million in nine SARS-CoV-2 vaccine candidates.
Built on the principles of speed, scale, and access, CEPI's diverse coronavirus vaccine portfolio includes many modern and innovative approaches to increase the world's chances of finding a safe, effective, and globally accessible vaccine. The goal is to speed up development of a successful vaccine to an accelerated 12-18-month timeframe.
Stevanato Group - which produces annually 10 billion units among drug delivery systems, sterile and bulk glass containers, plastic diagnostic and medical components, including proprietary products - has become a key supplier to CEPI’s COVID-19 vaccine programmes.
Related News
-
News CPHI North America 2024 – From the Floor
Welcome to Philly! CPHI North America once again graces the Philadelphia Convention Center, 7–9 May 2024. -
News Drug Patent Expiries: a steep cliff or opportunity for innovation?
The pharmaceutical industry faces a patent cliff together in the years leading up to 2030. Learn what this means for drug pricing, their outsourcing partners, and drug innovation of the future. -
News A Day in the Life of a President and Chief Scientific Officer
We are continuing to get to know the people working day-to-day behind the pharma companies shaping the industry, the ones who keep the wheels turning and ultimately bring better healthcare to the population; we are talking to the individuals at the hea... -
News Gerresheimer predicts weight-loss drug deals to account for 4% of yearly growth
Dietmar Siemssen, CEO of German primary packaging manufacturer Gerresheimer, states that approximately 4% of the company’s revenue growth each year to come from deals with drugmakers of weight loss and diabetes products, particularly GLP-1 class ... -
News LEAP-ing into the future of pharma – the CPHI Middle East Vision
On March 6, 2024, the CPHI team hosted the Future of Pharma Forum at LEAP 2024, Saudi Arabia’s premier destination for tech leaders and innovators to meet and collaborate. -
News Informa Markets International Women’s Day Panel Discussion
On March 7, 2024, the Informa Markets Amsterdam office hosted an International Women’s Day Breakfast and Panel Discussion to celebrate the women who drive the B2B events industry forward, including members of the CPHI team. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News CPHI Middle East 2024 – What do we have to look forward to?
We’re bringing CPHI to the Middle East in December 2024. CPHI brings together the pharma community from all over the world, creating a platform for education, collaboration, and progress.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance